These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 29353520)
1. Indications, complications, and outcomes following surgical management of locally advanced and metastatic renal cell carcinoma. González J; Gaynor JJ; Alameddine M; Esteban M; Ciancio G Expert Rev Anticancer Ther; 2018 Mar; 18(3):237-250. PubMed ID: 29353520 [TBL] [Abstract][Full Text] [Related]
2. Oncological outcomes after cytoreductive nephrectomy for patients with metastatic renal cell carcinoma with inferior vena caval tumor thrombus. Miyake H; Sugiyama T; Aki R; Matsushita Y; Tamura K; Motoyama D; Ito T; Otsuka A Int J Clin Oncol; 2018 Jun; 23(3):553-558. PubMed ID: 29332206 [TBL] [Abstract][Full Text] [Related]
3. Multimodal treatment of advanced renal cancer in 2017. Mennitto A; Verzoni E; Grassi P; Ratta R; Fucà G; Procopio G Expert Rev Clin Pharmacol; 2017 Dec; 10(12):1395-1402. PubMed ID: 28956645 [TBL] [Abstract][Full Text] [Related]
4. Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma in the era of targeted therapy: a bibliographic review. Faba OR; Brookman-May SD; Linares E; Breda A; Pisano F; Subiela JD; Sanguedolce F; Brausi M; Palou J World J Urol; 2017 Dec; 35(12):1807-1816. PubMed ID: 28702843 [TBL] [Abstract][Full Text] [Related]
5. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy. Karam JA; Wood CG Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966 [TBL] [Abstract][Full Text] [Related]
6. [Role of surgery (cytoreductive nephrectomy and metastasectomy) in the management of metastatic renal cell carcinoma: a literature review]. Arroua F; Maurin C; Carcenac A; Ragni E; Rossi D; Bastide C Prog Urol; 2010 Dec; 20(13):1175-83. PubMed ID: 21130395 [TBL] [Abstract][Full Text] [Related]
9. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy. Kwan KG; Kapoor A Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804 [TBL] [Abstract][Full Text] [Related]
10. Role of partial nephrectomy as cytoreduction in the management of metastatic renal cell carcinoma. Karam JA; Babaian KN; Tannir NM; Matin SF; Wood CG Minerva Urol Nefrol; 2015 Jun; 67(2):149-56. PubMed ID: 25645343 [TBL] [Abstract][Full Text] [Related]
11. Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Heng DY; Wells JC; Rini BI; Beuselinck B; Lee JL; Knox JJ; Bjarnason GA; Pal SK; Kollmannsberger CK; Yuasa T; Srinivas S; Donskov F; Bamias A; Wood LA; Ernst DS; Agarwal N; Vaishampayan UN; Rha SY; Kim JJ; Choueiri TK Eur Urol; 2014 Oct; 66(4):704-10. PubMed ID: 24931622 [TBL] [Abstract][Full Text] [Related]
12. International consultation on urologic diseases and the European Association of Urology international consultation on locally advanced renal cell carcinoma. Margulis V; Master VA; Cost NG; Leibovich BC; Joniau S; Kuczyk M; Mulders PF; Kirkali Z; Wirth MP; Hirao Y; Rawal S; Chong TW; Wood CG Eur Urol; 2011 Oct; 60(4):673-83. PubMed ID: 21752533 [TBL] [Abstract][Full Text] [Related]
13. Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when. Bex A; Powles T Expert Rev Anticancer Ther; 2012 Jun; 12(6):787-97. PubMed ID: 22716495 [TBL] [Abstract][Full Text] [Related]
14. Kidney autotransplantation after nephrectomy and work bench surgery as an ultimate approach to nephron-sparing surgery. Janssen MWW; Linxweiler J; Philipps I; Bütow Z; Siemer S; Stöckle M; Ohlmann CH World J Surg Oncol; 2018 Feb; 16(1):35. PubMed ID: 29463251 [TBL] [Abstract][Full Text] [Related]